Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHEZF research report →
About the company
Shenzhen Hepalink Pharmaceutical Group Co. , Ltd. , established in 1998 and headquartered in Shenzhen, People's Republic of China, operates as a global pharmaceutical enterprise.
- CEO
- Li Li
- IPO
- 2021
- Employees
- 1,926
- HQ
- Shenzhen, CN
Price Chart
- Market Cap
- $689.04M
- P/E
- 36.76
- P/S
- 2.20
- P/B
- 1.15
- EV/EBITDA
- 12.78
- Div Yield
- 1.52%
- Gross Margin
- 33.54%
- Op Margin
- 12.27%
- Net Margin
- 7.03%
- ROE
- 3.12%
- ROIC
- 3.76%
- Revenue
- $5.48B · 3.75%
- Net Income
- $349.49M · -45.96%
- EPS
- $0.24 · -45.45%
- Op Income
- $635.97M
- FCF YoY
- -20.06%
- 52W High
- $0.72
- 52W Low
- $0.47
- 50D MA
- $0.47
- 200D MA
- $0.47
- Beta
- 0.30
- Avg Volume
- 14.4
Get TickerSpark's AI analysis on SHEZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SHEZF coverage
Recent articles, reports, and earnings notes.
No research on SHEZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHEZF report →Similar companies
Peers in the same neighborhood.